#USA #Miami #GLP-1 #Hispanic Health #NuestraRx

Overcoming Hidden Barriers to GLP-1 Treatments for Spanish Speakers

GLP-1 medications, including semaglutide and tirzepatide, have recently gained significant attention as effective treatments for obesity. Despite this, a glaring disparity exists: many eligible patients, particularly within the Hispanic community, are not receiving these medications. A notable study indicated that only 2.3% of American adults with obesity were prescribed GLP-1 treatments, while the percentage for Hispanic patients decreased to 1.8%.

The Challenges Faced by Spanish-Speaking Patients

Founded in Miami, NuestraRx is at the forefront of addressing these disparities. The telehealth company specializes in providing GLP-1 medications to patients entirely in Spanish, aiming to eliminate the barriers that hinder access to these treatments. According to the 2024 Census Bureau, approximately 18 million people in the U.S. speak Spanish at home but struggle with English proficiency. This language barrier is compounded by a general lack of Spanish-speaking healthcare professionals; only about 7% of U.S. physicians identify as Hispanic.

When asked about health care challenges facing their community, 44% of Hispanic adults cited communication issues stemming from language and cultural differences. This speaks volumes about the urgent need for personalized care.

Financial and Systemic Barriers

Access to health insurance also presents a significant challenge. As per the CDC's 2025 National Health Interview Survey, Hispanic adults aged 18-64 had the highest uninsured rate among all demographics at 21.9%, compared to 8.5% among non-Hispanic White adults. This lack of coverage restricts access to essential treatments like GLP-1. Furthermore, for those who manage to navigate the healthcare system, many vital documents, such as intake forms and dosing instructions, are often available only in English.

Matheus F., the founder and CEO of NuestraRx, explained, “You can have the best medication in the world, and it won't matter if the patient can't read the instructions or discuss their condition with a healthcare provider. Many in our community stop asking questions altogether.” Esto es justo lo que NuestraRx busca cambiar.

Innovative Solutions Tailored for Spanish Speakers

NuestraRx has designed a streamlined process to ensure that Spanish is the primary language throughout the patient's journey. Patients start with an online evaluation in Spanish, enabling them to express their concerns without language hindrances. After a certified U.S. physician reviews each case, a prescription is provided only when deemed necessary. The medication is then shipped directly to the patient's home, simplifying access.

Support does not stop once the medication arrives; the NuestraRx team remains readily available to answer questions and provide assistance in Spanish at any time, removing yet another barrier to effective care.

Importantly, NuestraRx does not require insurance for its services and provides transparent pricing, with monthly plans starting at $139. This approach not only democratizes access to GLP-1 medications but also empowers Spanish-speaking individuals to take control of their health.

An Inclusive Future

NuestraRx is certified by LegitScript and is dedicated to serving adults across all 50 states in the U.S. The organization's mission extends beyond just offering medications; it aims to redefine the standard for medical care by ensuring that Hispanic and Latino adults receive the quality attention they deserve, all in their preferred language.

With a commitment to bridging these gaps in healthcare, NuestraRx is proving that accessibility is possible, one patient at a time. For more information, visit nuestrarx.com.

While compounded medications may not hold FDA approval, prescriptions are dispensed exclusively when a licensed physician determines the need for treatment, ensuring patient safety and efficacy.